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Background. Intrusive memories of traumatic events are a core feature of post-traumatic stress disorder but little is
known about the neurobiological formation of intrusions. The aim of this study was to determine whether the activity
of the noradrenergic system during an intrusion-inducing stressor would inﬂuence subsequent intrusive memories.
Method. We conducted an experimental, double-blind, placebo-controlled study in 118 healthy women. Participants
received a single dose of either 10 mg yohimbine, stimulating noradrenergic activity, or 0.15 mg clonidine, inhibiting nor-
adrenergic activity, or placebo. Subsequently, they watched an established trauma ﬁlm which induced intrusions. The
number of consecutive intrusions resulting from the trauma ﬁlm, the vividness of the intrusions, and the degree of dis-
tress evoked by the intrusions were assessed during the following 4 days. Salivary cortisol and α-amylase were collected
before and after the trauma ﬁlm.
Results. A signiﬁcant time × treatment interaction for the number of intrusions and the vividness of intrusions indicated
a different time course of intrusions depending on treatment. Post-hoc tests revealed a delayed decrease of intrusions and
a delayed decrease of intrusion vividness after the trauma ﬁlm in the yohimbine group compared with the clonidine and
placebo groups. Furthermore, after yohimbine administration, a signiﬁcant increase in salivary cortisol levels was
observed during the trauma ﬁlm.
Conclusions. Our ﬁndings indicate that pharmacological activation of the noradrenergic system during an emotionally
negative event makes an impact on consecutive intrusive memories and their vividness in healthy women. The noradre-
nergic system seems to be involved in the formation of intrusive memories.
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Introduction
Post-traumatic stress disorder (PTSD) can develop after
a traumatic stressor and it affects approximately 5.7%
of the general population in the USA (Kessler et al.
2005) and 1.1–2.9% in Europe (Wittchen et al. 2011).
Intrusive symptoms are a core feature of PTSD com-
prising, inter alia, recurrent, involuntary and intrusive
distressing traumatic memories (American Psychiatric
Association, 2013).
Rodent and human studies provide cumulative evi-
dence for the involvement of the noradrenergic system
in PTSD neurobiology (Krystal & Neumeister, 2009;
Bailey et al. 2013). For example, female adult PTSD
patients who have been sexually abused during child-
hood show increased 24-h urinary norepinephrine
(NE) compared with women who experienced child-
hood sexual abuse without PTSD diagnosis and non-
abused controls (Lemieux & Coe, 1995). Furthermore,
female and male war refugee PTSD patients show
increased salivary α-amylase (sAA) activity, an indica-
tor of increased noradrenergic activation (Van Stegeren
et al. 2006), after awakening compared with healthy
controls, and sAA secretion is positively associated
with reported PTSD symptoms (Thoma et al. 2012).
In addition, pharmacological interventions with the
α1 adrenergic antagonist prazosin, which blocks nora-
drenergic activation, have been shown to reduce
trauma-related nightmares compared with placebo in
women with PTSD (Taylor et al. 2006).
However, little is known about the neurobiological
inﬂuences on the formation of intrusions after traumat-
ic stress. The noradrenergic system could be involved,
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as indicated by studies in which a relationship between
increased NE and intrusive memories has been found
(Southwick et al. 1999). For example, in a study con-
ducted by Southwick et al. (1993), PTSD patients
were administered a single dose of yohimbine, an α2
selective antagonist that enhances noradrenergic acti-
vation, and placebo, each on a separate test day in a
double-blind, randomized balanced order. Of the
patients, 40% reported ﬂashbacks in the yohimbine
condition, while only 5% reported ﬂashbacks in the
placebo condition during the test day. Furthermore,
in male and female PTSD patients, it has been found
that the interaction of increased sAA activity and
increased salivary cortisol levels during the consolida-
tion of emotionally negative images predicts an in-
crease in intrusive memories (Nicholson et al. 2014).
Sex-speciﬁc biological stress mechanisms involved in
memory consolidation (Andreano & Cahill, 2009)
might be responsible for the inconsistent sex differ-
ences in intrusive memories in men and women
(Felmingham et al. 2012; Bryant et al. 2013). For ex-
ample, women who underwent a cold pressor test be-
fore seeing emotionally negative images recalled more
negative images after 2 days compared with men
(Felmingham et al. 2012). Cortisol levels after the cold
pressor test predicted the number of recalled negative
images in women, and neutral images in men
(Felmingham et al. 2012). In contrast, the interaction
of increased sAA activity and increased salivary corti-
sol levels during the consolidation of emotionally
negative images predicts an increase in intrusive mem-
ories in men but not in women (Bryant et al. 2013).
The lack of suitable experimental designs to examine
the neurobiology of the formation of intrusive memor-
ies has so far limited the number of studies. Recently,
trauma ﬁlm paradigms have been shown to induce
short-lasting intrusive memories in healthy individuals
(e.g. Holmes & Bourne, 2008). The only study that has,
so far, examined associations among salivary cortisol,
sAA, and intrusion formation within the trauma ﬁlm
paradigm found a positive correlation between post-
ﬁlm salivary cortisol levels and the frequency of intru-
sions, however, only in individuals with increased
sAA activity (Chou et al. 2014).
In contrast to the scarce evidence regarding the inﬂu-
ence of the noradrenergic stress system on intrusion
formation, there are a large number of studies investi-
gating the inﬂuence of the noradrenergic system on
other aspects of memory and emotional learning in
humans (Van Stegeren, 2008; Roozendaal & McGaugh,
2011; Schwabe et al. 2012). The administration of adren-
ergic receptor blockers (e.g. propranolol) leads to
impaired memory performance for emotional events
and stimuli in humans, while pharmacological nora-
drenergic activation (e.g. yohimbine) during encoding
and consolidation enhances memory for emotional
stimuli in the majority of studies (Chamberlain &
Robbins, 2013). A positive association between sAA,
assessed shortly after the presentation of emotionally
arousing pictures, and memory of these pictures 1
week later has been found in healthy participants
(Segal & Cahill, 2009).
In addition to the catecholaminergic system, the
hypothalamus–pituitary–adrenal (HPA) axis releases
cortisol when it is activated, and has an impact on
the formation of emotional memory during encoding
and consolidation in healthy individuals (Schwabe
et al. 2012; Finsterwald & Alberini, 2014). For instance,
elevated cortisol levels during encoding and consolida-
tion after administration of hydrocortisone improve
memory performance for emotionally arousing pic-
tures compared with neutral pictures (Kuhlmann &
Wolf, 2006). Therefore, cortisol levels during trauma
might be relevant in the formation of intrusions.
The aim of the current study was to examine the po-
tential inﬂuence of noradrenergic activity during trau-
matic stress (trauma ﬁlm) in healthy women on the
consecutive development of intrusive memories in an
experimental design. We hypothesized that noradre-
nergic activation would lead to an increased number
of intrusive memories of the trauma ﬁlm, more vivid
intrusions, and more distressing intrusions of the
trauma ﬁlm compared with placebo and inhibited nor-
adrenergic activity. In addition, it was hypothesized
that lower noradrenergic activity would lead to a
decreased number of intrusions, decreased vividness




A total of 118 healthy university students were
recruited via ofﬁcial university email lists or public
postings. As the rape victim in the trauma ﬁlm is fe-
male, the sample was restricted to women to increase
homogeneity of our sample. Furthermore, pilot runs
with the trauma ﬁlm including male and female
participants had shown that men did not identify
themselves with the victim but rather with a male
witness. Exclusion criteria included former or present
Diagnostic and Statistical Manual of Mental
Disorders, 4th edition (DSM-IV) Axis I disorders
(assessed by the Structured Clinical Interview for
DSM-IV Axis I Disorders; German version of First
et al. 1995), physical illnesses, any medication intake
(except oral contraceptive), history of sexual abuse or
rape, and pregnancy or lactation period. The HCG
ULTRA pregnancy test was implemented to exclude
2524 F. Rombold et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291716001379
Downloaded from https://www.cambridge.org/core. Charite Universitaetsmedizin Berlin, on 01 Dec 2017 at 13:00:32, subject to the Cambridge Core terms of use, available at
pregnancy. All women were between 18 and 44 years
old (see Table 1) and spoke German on a native
level. Out of the 118 participants, four women were
excluded: two participants withdrew from the study
after having watched the ﬁlm for several minutes,
one participant was excluded due to fatigue during
the session after taking clonidine, and one participant
was excluded due to missing diary data. This resulted
in the ﬁnal sample size of n = 114. All participants
received ﬁnancial remuneration (35€).
Procedure
The randomized, double-blind, placebo-controlled
study was conducted at the Department of Psychiatry
and Psychotherapy, Campus Benjamin Franklin, Char-
ité – Universitätsmedizin Berlin, and was approved by
the local ethics committee. Participants were asked to
refrain from smoking, physical exercise, eating, con-
suming caffeine, and drinking alcohol or other bev-
erages (except for water) at least 1 h prior to the
assessment. Written informed consent was obtained
at least 24 h before the assessment. Each participant
was tested on a separate day.
Experimental phase
Participants were randomly assigned to either
clonidine (0.15 mg), inhibiting noradrenergic activity,
placebo, or yohimbine (10 mg), stimulating noradre-
nergic activity. The pills for both drugs as well as the
placebo looked identical, hence ensuring that the ex-
perimenter was also blind to the experimental
condition.
Administration was conducted 60 min before the
trauma ﬁlm, since peak plasma levels of oral clonidine
occur after 60–90 min with an elimination half-life of
about 6 to 12 h (Reid, 1981) and oral yohimbine
peaks in plasma after 45–60 min with an elimination
half-life of about 0.60 (S.D. = 0.25) h (Owen et al. 1987).
Potential effects of the medication and the trauma
ﬁlm on salivary cortisol levels, sAA activity and
blood pressure were measured at seven time points
during the study. To do so, saliva was collected and
blood pressure was measured by an automatic device
(BoSo Medicus Uno; Bosch + Sohn, Germany) at base-
line, after medication intake, and ﬁve times after the
trauma ﬁlm. The Childhood Trauma Questionnaire
(CTQ; German version of Bernstein & Fink, 1998)
was utilized to control for differences in experienced
childhood events, as childhood trauma has been
shown to be associated with noradrenergic responses
to stress (Otte et al. 2005) and with an increased risk
of PTSD after trauma in adulthood (Breslau et al.
1999). Since PTSD is positively related to pre-trauma
trait anxiety (McNally et al. 2011), the trait scale of
the State-Trait Anxiety Inventory (German version
of Spielberger & Gorsuch, 1983) was applied. After
the assessment, participants completed the intrusion
diary for the next 4 days. Participants were instructed
to not talk to other potential participants about the
content of the study.
Follow-up session
After 7 days, the diary was returned and The Impact of
Event Questionnaire (German version of Horowitz
et al. 1979) was applied to evaluate PTSD-related
symptoms: intrusion, avoidance and hyperarousal. In
order to not inform participants about the trauma
ﬁlm before the experimental phase, they were asked
at the end of the study if they had seen the ﬁlm
‘Irréversible’ before. After 4 weeks the participants
were contacted and The Impact of Event Questionnaire
was conducted again via phone. At the end of the
study a debrieﬁng was provided via phone and in
written form.
Trauma ﬁlm and intrusion diary
The trauma ﬁlm paradigm was adopted, using a ﬁlm
scene which is particularly suitable for evoking short-
lasting intrusions in healthy participants and which
has been used in previous studies (Weidmann et al.
2009). The scene from the ﬁlm ‘Irréversible’ (directed
by Gaspar Noé, 2002) was shown to all participants,
depicting a scene (14 min, 40 s) in which a woman is
raped by a man. The ﬁlm was shown on a 2 × 2.5 m
screen. The sound was played through headphones.
The female researcher was present while the partici-
pant watched the ﬁlm.
A pencil-and-paper diary (Holmes et al. 2004;
Weidmann et al. 2009) was used to record intrusions
throughout the following 4 days. Participants were
instructed to ‘record any spontaneously occurring
memory from the trauma ﬁlm’ instantaneously after
occurrence. The difference between image- and
thought-based memories was explained to the partici-
pant. According to Holmes et al. (2004), memories in
the diary were speciﬁed by spontaneity of appearance,
frequency, modality (image, thought based, or both),
content, vividness and the degree of distress.
Vividness and degree of distress of every single intru-
sion were rated from 0 (‘not at all’) to 5 (‘a lot’) and
evaluated by summing up daily ratings. A text mes-
sage was sent at 21.00 hours daily to remind partici-
pants to transfer inscriptions from their pencil-and-
paper diary to an identical online diary to assure
participation. When participants turned in the diary,
the researcher went through every single memory
with them and rated whether the respective memory
was intrusive or not. Only memories which occurred
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spontaneously and included imagery with vividness
and degree of distress >0 were considered intrusive
and included in the analyses (Ehlers et al. 2004; Arntz
et al. 2005). The researchers were trained how to rate
the intrusions following a protocol. Further, they
were instructed to contact the principal investigator
(who was also blind to group membership) in case of
uncertainty how to rate the intrusions. This was only
the case twice at the beginning of the study. The inter-
rater reliability of this approach proved to be excellent
in a study with a similar intrusion assessment (intra-
class correlation = 0.997; Hagenaars & Arntz, 2012).
Salivary assessment
Saliva samples were collected in order to determine
salivary free cortisol and sAA (Salivettes®, blue cap;
Sarstedt). To ensure homogeneous saliva collection
from all salivary glands, participants were instructed
to move the cotton swab in their mouth in a circular
pattern for 1 min without actively chewing on it
(Nater & Rohleder, 2009). Samples were subsequently
stored at −20°C before biochemical analyses were per-
formed in the Neurobiology Laboratory of the Depart-
ment of Psychiatry, Charité – Universitätsmedizin
Berlin. Salivary cortisol was analysed using a commer-
cially available TR-FRET-based, in-house adopted
immunoassay (Cisbio International), which was per-
formed in principle according to the manufacturer’s
instructions (see online Supplementary material for
details). Inter- and intra-assay coefﬁcients of variation
were below 12%. sAA activity was determined using
a modiﬁed protocol (see online Supplementary mater-
ial for details) of a previously published direct
α-amylase assay (Lorentz et al. 1999). Inter- and
intra-assay coefﬁcients of variation were both lower
than 10% for sAA activity.
Statistical analysis
Statistical analyses were performed using SPSS version
22.0 (USA). Statistical signiﬁcance refers to a p value
<0.05. Differences between treatment groups in demo-
graphic baseline variables and in the conducted ques-
tionnaires during the study were tested by univariate
analysis of variance (ANOVA) for continuous data
and Pearson’s χ2 test for categorical data. For total cor-
tisol, the area under the curve (AUC) was calculated
(Pruessner et al. 2003). Pearson’s correlation analyses
were performed to analyse a possible association be-
tween salivary cortisol (AUC), cortisol peak value
(peak – baseline), number of intrusions, vividness of
intrusions, and degree of distress evoked by intrusions.
Three sets of repeated-measures mixed-design
ANOVA were used to test the effects of treatment
(between-subjects factor) and time (within-subjects
variable with seven levels) on salivary cortisol levels,
sAA and blood pressure. Furthermore, ANOVA was
conducted to examine the effects of treatment
(between-subjects factor) and time (within-subjects
variable with four levels) on number of intrusions, viv-
idness, and degree of distress as dependent variables.
For repeated-measures ANOVA, ηp
2 was used as effect
size. In all ANOVAs, homogeneity of variance was
assessed by Levene’s statistic and sphericity was exam-
ined with Mauchly’s test. Since the assumption of
sphericity was never met, Greenhouse–Geisser-
corrected p values are reported. For post-hoc compari-
sons, a Bonferroni correction for multiple comparisons
was performed.
An a priori power analysis revealed that a sample
size of 105 yields high power (0.95) to detect a small ef-
fect size (ηp
2 = 0.03) at p < 0.05 in a three-group design
using repeated-measures ANOVAs (G*Power 3.1;
Faul et al. 2007). To take drop-outs into account, sam-
ple size was set to 118 participants.
Table 1. Sample characteristics
Characteristic Clonidine (n = 38) Placebo (n = 38) Yohimbine (n = 38) Statistics p
Mean age, years (S.D.) 23.3 (3.6) 23.1 (3.2) 23.4 (4.5) F2,111 = 0.08 0.93
Intake of oral contraceptives, n (%) 19 (50.0) 22 (57.9) 13 (34.2) χ22 = 4.43 0.11
Current smoker, n (%) 8 (21.1) 4 (10.5) 9 (23.7) χ22 = 2.45 0.29
Menstrual cycle, n (%) χ22 = 1.02 0.62
Follicular phase 18 (50) 18 (47.4) 20 (58.8)
Luteal phase 18 (50) 20 (52.6) 14 (41.2)
Mean BMI, kg/m2 (S.D.) 21.2 (2.6) 22.4 (3.2) 21.8 (3.0) F2,110 = 1.57 0.21
Mean CTQ (S.D.) 37.4 (9.1) 38.3 (10.0) 36.1 (6.1) F2,111 = 0.66 0.52
Mean STAI-T (S.D.) 37.2 (7.0) 37.6 (7.1) 35.7 (6.8) F2,111 = 0.81 0.45
Participants who had seen the ﬁlm before, n (%) 2 (1.8) 4 (3.5) 1 (0.9) χ22 = 2.24 0.33
S.D., Standard deviation; BMI, body mass index; CTQ, Childhood Trauma Questionnaire; STAI-T, trait scale of the Trait
Anxiety Inventory.
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Results
Participant characteristics
The three groups did not differ in any of the demo-
graphic variables or possible confounders (see Table 1).
sAA and blood pressure
sAA activity throughout the assessment is displayed in
Fig. 1. There was a signiﬁcant effect of time (F3.98,421.71
= 13.57, p < 0.01, ηp
2 = 0.11) as well as a signiﬁcant
effect of treatment (F2,106 = 7.41, p < 0.01, ηp
2 = 0.12).
Furthermore, a signiﬁcant time x treatment interaction
(F7.96,421.71 = 3.14, p < 0.01, ηp
2 = 0.06) was revealed.
Groups did not differ at baseline (p > 0.05). Post-hoc
tests revealed that yohimbine led to higher sAA activ-
ity compared with placebo and clonidine (p < 0.05).
Diastolic blood pressure and systolic blood pressure
are displayed in Figs 2 and 3. There was a signiﬁcant
effect of time and treatment for diastolic (F3.91,430.57 =
10.65, p < 0.01, ηp
2 = 0.09, F2,110 = 33.36, p < 0.01, ηp
2 =
0.38) and systolic (F4.13,454.52 = 16.43, p < 0.01, ηp
2 = 0.13,
F2,110 = 28.42, p < 0.01, ηp
2 = 0.34) blood pressure. The
interaction effect of time x treatment was signiﬁcant
for diastolic (F7.83,430.57 = 11.16, p < 0.01, ηp
2 = 0.17) and
systolic blood pressure (F8.26,454.52 = 8.35, p < 0.01, ηp
2 =
0.13), indicating that clonidine decreased diastolic
(p < 0.01) and systolic (p < 0.01) blood pressure com-
pared with yohimbine and placebo.
Salivary cortisol
Salivary cortisol levels for the three experimental
groups are displayed in Fig. 4. While there was no
treatment effect (F2,107 = 2.00, p = 0.15), the effect of
time was signiﬁcant (F2.00,214.29 = 3.52, p < 0.01, ηp
2 =
0.03). Furthermore, the time x treatment interaction
was signiﬁcant (F4.01,214.29 = 3.37, p = 0.01, ηp
2 = 0.06).
Post-hoc tests revealed no difference in salivary cortisol
levels between the three groups at baseline (p > 0.05).
Furthermore, post-hoc tests revealed higher salivary
cortisol levels in the yohimbine group compared with
the placebo group (p < 0.05) and also compared with
the clonidine group on a trend level (p < 0.1).
Fig. 1. Salivary α-amylase activity at baseline and before and after the trauma ﬁlm for the clonidine, placebo and yohimbine
groups. Values are means, with standard errors represented by vertical bars. * Signiﬁcant differences between the yohimbine
and placebo groups, and the yohimbine and clonidine groups (p < 0.05).
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Intrusions
As expected, the number of intrusions declined over
time (F2.47,273.81 = 65.24, p < 0.01, ηp
2 = 0.38). While there
was no signiﬁcant effect of treatment (F2,111 = 1.00,
p = 0.37), a signiﬁcant time x treatment interaction
was observed (F4.93,3.0 = 2.97, p = 0.01, ηp
2 = 0.05), indicat-
ing a delayed decrease in the number of intrusive
memories in the yohimbine group compared with the
clonidine and placebo groups. The interaction is dis-
played in Fig. 5. Post-hoc tests revealed that partici-
pants in the yohimbine group reported more
intrusive memories of the trauma ﬁlm on the ﬁrst
day after the trauma ﬁlm than participants in the cloni-
dine (p = 0.02) and placebo (p = 0.03) groups.
As expected, the vividness of intrusive memories
also declined over time (F2.38,264.55 = 32.32, p < 0.01,
ηp
2 = 0.23). While there was no signiﬁcant effect of
treatment (F2,111 = 1.34, p = 0.27), the time x treatment
interaction was signiﬁcant (F4.77,264.55 = 2.55, p = 0.03,
ηp
2 = 0.04), indicating a delayed decrease in the vivid-
ness of intrusive memories in the yohimbine group
compared with the clonidine and placebo groups.
The interaction is displayed in Fig. 6. Again, on the
ﬁrst day after the trauma ﬁlm the reported vividness
of the intrusions in the yohimbine group was signiﬁ-
cantly higher than in the placebo (p = 0.03) and cloni-
dine (p = 0.02) groups.
Yohimbine, clonidine and placebo did not affect the
degree of distress that participants experienced
through the intrusive memories (no effect of treatment,
F2,111 = 1.17, p = 0.31 and no treatment x time inter-
action, F4.76,264.40 = 1.73, p = 0.11). However, there was
a signiﬁcant effect of time (F2.39,264.40 = 59.84, p < 0.01,
ηp
2 = 0.36), indicating a decline of distress over the
course of 4 days.
Including sAA activity and cortisol levels (‘AUCs’),
childhood trauma (CTQ; German version of Bernstein
& Fink, 1998), or intake of oral contraceptives separate-
ly as covariates in the general linear model did
not modify the signiﬁcance of the interaction effect
(time × treatment) for the number of intrusions and
Fig. 2. Diastolic blood pressure at baseline and before and after the trauma ﬁlm for the clonidine, placebo and yohimbine
groups. Values are means, with standard errors represented by vertical bars. * Signiﬁcant differences between the clonidine
and yohimbine groups, and the clonidine and placebo groups (p < 0.01).
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vividness. Further, the number of intrusions, the vivid-
ness of intrusions, and the degree of distress evoked by
the intrusions were not associated with the cortisol re-
sponse (AUC and peak value; all r values <0.1, all
p values >0.05).
The Impact of Event Questionnaire
The Impact of Event Questionnaire (German version of
Horowitz et al. 1979) did not show any differences in
PTSD-related symptoms between the yohimbine, cloni-
dine, and placebo groups 1 week (F2,108 = 0.25, p = 0.78)
and 4 weeks after the assessment (F2,107 = 0.32, p = 0.72).
Discussion
We examined the inﬂuence of the noradrenergic sys-
tem on encoding and consolidation of potentially in-
trusive memories after a trauma ﬁlm paradigm in
healthy women. Prior to the trauma ﬁlm, participants
received either yohimbine to stimulate noradrenergic
activity, or clonidine to inhibit noradrenergic activity,
or placebo. Intrusions occurring throughout the fol-
lowing 4 days were recorded.
After yohimbine the number of intrusive memories
as well as their vividness showed a delayed decrease
compared with clonidine and placebo over the 4 days
following the trauma ﬁlm. These ﬁndings might be
relevant for future studies because it has been shown
that intrusions during the days and weeks after a
trauma predict a PTSD diagnosis later on (Shalev
et al. 1996; Ehlers, 2010).
Our results extend recent ﬁndings of a study by
Bryant et al. (2013), which showed that healthy partici-
pants reported more unintentional memories of
depicted negative images after being stressed during
consolidation compared with non-stressed partici-
pants. In this study, an interaction of increased salivary
cortisol levels and sAA activity during consolidation
predicted more unintentional memories in men but
not in women (Bryant et al. 2013). So far, a single
study has examined the inﬂuence of sAA and salivary
Fig. 3. Systolic blood pressure at baseline and before and after the trauma ﬁlm for the clonidine, placebo and yohimbine
groups. Values are means, with standard errors represented by vertical bars. * Signiﬁcant differences between the clonidine
and yohimbine groups, and the clonidine and placebo groups (p < 0.01).
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cortisol during encoding and consolidation on subse-
quent intrusions within the trauma ﬁlm paradigm
but without manipulating glucocorticoid and nor-
adrenaline signalling (Chou et al. 2014). However, in
this study, sAA activity during encoding and consoli-
dation did not predict the vividness of subsequent
intrusions in men and women. Also, peri-ﬁlm sAA
activity was not associated with the number of intru-
sions. However, a positive correlation between post-
ﬁlm salivary cortisol levels and the number of
intrusions was found in individuals with increased
sAA activity (Chou et al. 2014).
A strong increase in salivary cortisol levels 15 min
after the end of the trauma ﬁlm in the yohimbine con-
dition was found. Contradictory ﬁndings exist on the
inﬂuence of yohimbine administration on salivary cor-
tisol levels in healthy controls. Some ﬁndings indicate
enhanced salivary cortisol levels after yohimbine ad-
ministration (Sommer et al. 2011) and others indicate
no effect of yohimbine on salivary cortisol levels in
controls (Gurguis et al. 1997). In our study, noradrener-
gic activation after yohimbine during the trauma ﬁlm
might have served as a facilitator of the cortisol re-
sponse to stress. This, again, might have resulted in
the delayed decline of intrusions and their vividness
in the yohimbine condition. This mechanism would
be in line with ﬁndings suggesting that glucocorticoids
enhance memory consolidation of emotional stimuli
when noradrenergic activity during encoding is
increased (Roozendaal et al. 2006). For example, it has
been shown that memory for emotional images 1
week after encoding is enhanced by hydrocortisone ad-
ministration in participants with increased noradrener-
gic activity at the time of encoding, while this is not the
case for participants with hydrocortisone administra-
tion but without noradrenergic increase and partici-
pants in the placebo condition (Segal et al. 2014).
So far, there are no other experimental studies exam-
ining the effects of manipulating the noradrenergic sys-
tem during encoding and consolidation of stressful or
Fig. 4. Salivary cortisol levels at baseline and before and after the trauma ﬁlm for the clonidine, placebo and yohimbine
groups. Values are means, with standard errors represented by vertical bars. * Signiﬁcant differences between the yohimbine
and placebo groups (p < 0.05), and difference on a trend level (p < 0.1) between the yohimbine and clonidine groups.
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traumatic events on intrusions. However, our ﬁndings
seem to be in line with data on stress and emotional
memory in rodents and humans. Our results are com-
patible with data from animal studies suggesting
enhanced fear memory after noradrenergic activation
during consolidation (Dębiec et al. 2011; Gazarini
et al. 2013). Furthermore, the consolidation of emotion-
al events in healthy participants seems to be enhanced
by stress (Smeets et al. 2008; Segal & Cahill, 2009).
No differences in the number of intrusions and their
vividness between the clonidine and placebo groups
were found. Therefore, noradrenergic inhibition via
the α2 receptor during trauma does not seem to inﬂu-
ence consecutive intrusions, at least in healthy young
women and in response to a relatively mild experimen-
tal stressor. Several studies examining emotional mem-
ories in humans after β-adrenergic blockade during
encoding have reported reduced memory performance
for emotional material (Strange et al. 2003; Van
Stegeren, 2008). Furthermore, healthy participants
show impaired memory in a word list paradigm after
administration of a single dose of clonidine during
consolidation compared with placebo (Kuffel et al.
2014). In line with these results, a single dose of yohim-
bine during consolidation after a word list paradigm
improves memory performance compared with pla-
cebo (Wingenfeld et al. 2013). A mechanism underlying
the fact that intrusions did not differ between the clo-
nidine and placebo groups could be the activity of
the HPA axis, which did not differ with respect to sal-
iva cortisol between both groups. Furthermore, a ﬂoor
effect might be responsible for the failure to ﬁnd an ef-
fect of clonidine.
There are some limitations to this study. The sample
was restricted to women and female sex hormones
may make an impact on intrusive memories (Cheung
et al. 2013). Therefore, the results might not be applic-
able to men. Also, participants taking oral contracep-
tives were not excluded and the cycle phase was not
matched. We did, however, control for both. The lack
of effect of clonidine on intrusion formation might be
related to the relatively small dosage; however,
Fig. 5. Number of the intrusive memories for the yohimbine, placebo and clonidine groups over 4 days, starting on the day
when the trauma ﬁlm was shown to the participants. Values are means, with standard errors represented by vertical bars.
* Signiﬁcant differences between the yohimbine and placebo groups, and the yohimbine and clonidine groups (p < 0.05).
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clonidine decreased diastolic and systolic blood pres-
sure compared with yohimbine and placebo, and sed-
ation of the participants at a higher dosage has to be
considered. Previous studies have shown that a dosage
of 0.15 mg is sufﬁcient to impair memory consolidation
in healthy controls (Kuffel et al. 2014). Additionally, a
higher dosage (0.3 mg) compared with a lower dosage
(0.15 mg) has been shown to have the same effect on
the formation of memory in healthy controls (Tiplady
et al. 2005). Further, due to the elimination half-life of
clonidine and yohimbine, clonidine effects were pre-
sent during encoding and most of consolidation,
whereas yohimbine effects were only present during
encoding and early consolidation. Furthermore, in
our study design the duration of action of clonidine
and yohimbine made it impossible to distinguish be-
tween noradrenergic effects during encoding or con-
solidation of the trauma ﬁlm on the development of
intrusions. This distinction might be especially import-
ant regarding future medical treatment interventions,
which could more easily be administered during con-
solidation after the trauma, than during encoding of
the traumatic event. Additionally, the decrease of viv-
idness and number of intrusions in the yohimbine
group was only of small effect size. The inﬂuence of
the noradrenergic system on consecutive intrusions
after real trauma and clinical signiﬁcance needs to be
elucidated. Furthermore, the self-report of intrusive
memories might be inaccurate if the participants fail
to recognize the intrusions or do not report them
(Takarangi et al. 2014). However, participants’ compli-
ance was increased by the daily transfer of recorded
intrusions from the paper to the online diary and the
reminder per text message.
Future research should focus on investigating the ef-
fect of the noradrenergic system and the HPA axis on
the formation of intrusions separately by respectively
blocking one of the systems. Furthermore, the inﬂuence
of the noradrenergic system on consecutive intrusions
should be evaluated in men and with other trauma
ﬁlm paradigms. In summary, a delayed decrease in in-
trusive memories as well as a delayed decrease in their
vividness after yohimbine administration compared
with clonidine and placebo was found. These results
Fig. 6. Vividness of the intrusive memories for the yohimbine, placebo and clonidine groups over 4 days, starting on the day
when the trauma ﬁlm was shown to the participants. Values are means, with standard errors represented by vertical bars.
* Signiﬁcant differences between the yohimbine and placebo groups, and the yohimbine and clonidine groups (p < 0.05).
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suggest an inﬂuence of noradrenergic activation on
intrusion formation. These ﬁndings contribute to a better
understanding of the neurobiological formation of
intrusive memories in healthy individuals without his-
tory of trauma exposure. The ﬁndings suggest potential
mechanisms for animal and human models of PTSD.
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